CA
NZ
UK
AU
IND
US
Luda Technology Group Limited filed a Report of Foreign Private Issuer on November 9, 2026, announcing a new coal trading agreement with Shanghai Shouying Huifu Energy Development Co., Ltd. covering 1.05 million metric tons.
Veradermics, Incorporated filed a Form 8-K on November 9, 2026, disclosing positive topline results from Part B of its Phase 2/3 clinical trial, Study '302', evaluating investigational oral minoxidil formulation VDPHL01 in males with mild-to-moderate pattern hair loss.
Delcath Systems, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting continued profitability and revenue growth.
OBOOK Holdings Inc. filed a Form 6-K with the SEC on November 9, 2026, disclosing a Securities Purchase Agreement dated November 6, 2026, with Lind Global Asset Management XV LLC for a second secured convertible note financing generating aggregate gross proceeds of US$5,000,000.
Coursera, Inc. filed a Form 8-A on November 9, 2026 to register Preferred Stock Purchase Rights on the New York Stock Exchange in connection with the company's adoption of a new stockholder rights plan.
Uxin Ltd Chief Executive Officer and Director Dai Kun filed a Form 4 on November 9, 2026, disclosing a purchase of 8,245 American depositary shares on November 6, 2026, made pursuant to a Rule 10b5-1 plan.
Capstone Holding Corp. filed a Form 8-K on November 9, 2026, disclosing two agreements executed on November 6, 2026: a First Amendment to its Senior Secured Convertible Note with 3i, LP and a Second Amendment to its Amended and Restated Common Stock Purchase Agreement …
Stefan Chkautovich, Chief Financial Officer of Southern Missouri Bancorp, Inc., filed a Form 4 on November 9, 2026, disclosing option exercises and changes in beneficial ownership of common stock dated November 5, 2026.
Coursera, Inc. filed a Form 8-K on November 9, 2026, disclosing that its board of directors adopted a stockholder rights plan on November 7, 2026, in response to a stockholder accumulating approximately 14.7% of the company's outstanding common stock.
Director Andrew Lauck filed a Form 4 with the SEC on November 9, 2026, disclosing an open-market purchase of Class A common stock in Strata Critical Medical, Inc. (NASDAQ:SRTA) on November 5, 2026.
Please wait processing your request...